By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher this morning reported revenues for its second quarter grew 24 percent year over year, as sales in its Medical Technologies segment grew 31 percent for the period, helped along by its recent purchases of AB Sciex and Molecular Devices.

For the three months ended July 2, revenues grew to $3.31 billion from $2.67 billion in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.